GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Cowin Biotech Co Ltd (SHSE:688426) » Definitions » EV-to-Revenue

Jiangsu Cowin Biotech Co (SHSE:688426) EV-to-Revenue : 16.13 (As of Dec. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Cowin Biotech Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Jiangsu Cowin Biotech Co's enterprise value is ¥1,906.0 Mil. Jiangsu Cowin Biotech Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ¥118.2 Mil. Therefore, Jiangsu Cowin Biotech Co's EV-to-Revenue for today is 16.13.

The historical rank and industry rank for Jiangsu Cowin Biotech Co's EV-to-Revenue or its related term are showing as below:

SHSE:688426' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.85   Med: 8.65   Max: 21.67
Current: 16.4

During the past 6 years, the highest EV-to-Revenue of Jiangsu Cowin Biotech Co was 21.67. The lowest was 2.85. And the median was 8.65.

SHSE:688426's EV-to-Revenue is ranked worse than
65.26% of 1042 companies
in the Biotechnology industry
Industry Median: 7.54 vs SHSE:688426: 16.40

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-15), Jiangsu Cowin Biotech Co's stock price is ¥21.40. Jiangsu Cowin Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.01. Therefore, Jiangsu Cowin Biotech Co's PS Ratio for today is 21.15.


Jiangsu Cowin Biotech Co EV-to-Revenue Historical Data

The historical data trend for Jiangsu Cowin Biotech Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Cowin Biotech Co EV-to-Revenue Chart

Jiangsu Cowin Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - - 3.70 15.08

Jiangsu Cowin Biotech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.69 15.08 13.10 12.12 15.58

Competitive Comparison of Jiangsu Cowin Biotech Co's EV-to-Revenue

For the Biotechnology subindustry, Jiangsu Cowin Biotech Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Cowin Biotech Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Cowin Biotech Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Jiangsu Cowin Biotech Co's EV-to-Revenue falls into.



Jiangsu Cowin Biotech Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Jiangsu Cowin Biotech Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1905.988/118.171
=16.13

Jiangsu Cowin Biotech Co's current Enterprise Value is ¥1,906.0 Mil.
Jiangsu Cowin Biotech Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥118.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Cowin Biotech Co  (SHSE:688426) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Jiangsu Cowin Biotech Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=21.40/1.012
=21.15

Jiangsu Cowin Biotech Co's share price for today is ¥21.40.
Jiangsu Cowin Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Cowin Biotech Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Jiangsu Cowin Biotech Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Cowin Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Yaocheng Avenue, 4th Floor, TQB Building, Jiangsu Province, Taizhou, CHN, 225300
Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.
Executives
Yin Jian Feng Director
Zhuang Zhi Hua Directors, senior managers

Jiangsu Cowin Biotech Co Headlines

No Headlines